A study finds that the expanded CFvantage® panel, which detects up to 155 CFTR mutations, identified pathogenic CFTR mutations in a substantial proportion of samples that would have been missed by testing with the 23-mutation panel alone. Learn more about the October 8, 2015 poster presentation that took place at the American Society of Human Genetics Annual Meeting.
Compared to the general population, a woman with a confirmed BRCA1 or BRCA2 mutation is at greater risk of developing cancer during her lifetime—up to an 85% risk of breast cancer and up to a 40% risk of ovarian cancer. Her children, siblings and parents have a 50% chance of having the same autosomal dominant mutation and facing comparable risks.
WebinarsView All Webinars >
Dr. Martin Bergman discusses the primary screen and testing for autoimmune diseases: "ANA- The Misunderstood Lab Test" Read more
Dr. Ashizawa will discuss when and why healthcare professionals should order DNA testing for ataxia, and discusses the future of DNA testing - whole exome... Read more
Dr. Cesar Molina discusses the benefits of diet, exercise and stress reduction in the treatment and prevention of coronary heart disease. ASCLS P.A.C.E.® credits are... Read more
Expert InsightsView All Expert Insights >
PublicationsView All Publications >
Nassar A, Cohen C, Zhou W, Lynch KA, Barker EA, Vanderbilt BL, Thompson J, Heyman ER, Olson A, Lange H, Siddiqui MT.Bandino JP, Kazlouskaya V, Ergin S, Moles-Proveda P, Cleaver NJ, Kabigting FD, Shackelton JB, Thieu K
J Cutan Pathol 2015
Determination of HIV-1 coreceptor tropism using proviral DNA in women before and after viral suppression.
Nassar A, Cohen C, Zhou W, Lynch KA, Barker EA, Vanderbilt BL, Thompson J, Heyman ER, Olson A, Lange H, Siddiqui MT.Burger H, Weiser B, Gao W, Anastos K, Young M
AIDS Res Ther 2015;12:11
Use of a picosecond pulse duration laser with specialized optic for treatment of facial acne scarring.
Nassar A, Cohen C, Zhou W, Lynch KA, Barker EA, Vanderbilt BL, Thompson J, Heyman ER, Olson A, Lange H, Siddiqui MT.Brauer JA, Kazlouskaya Y, Alabdulrazzaq H, Bae YS, Bernstein LJ, Anolik R, Geronemus RG
JAMA Dermatol 2015;151:278-284